Moreover, non-direct inhibition of the PTN signaling pathway by ribozymes targeted at ALK gene mRNA (which encodes a tyrosine kinase receptor for PTN ) caused a 50-95% retardation of tumor growth and a two-fold increase in the mean survival time for mice with grafted glioblastoma [143]. Here, ALK is linked to neoplasm.